Although the two cKIT mutations detected in this case report have never been associated with IMA resistance and are unlikely to lead to disease progression, a liquid biopsy approach could be considered to noninvasively detect the onset of disease progression even in GIST. This evidence concerns the gene KIT and gastrointestinal stromal tumor.